Blackberry is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nelco Laboratories, Inc.. The primary component is Blackberry.
| Product ID | 36987-1301_255e0c54-6613-460b-a91f-452fdfd0319d | 
| NDC | 36987-1301 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Blackberry | 
| Generic Name | Blackberry | 
| Dosage Form | Injection, Solution | 
| Route of Administration | INTRADERMAL; SUBCUTANEOUS | 
| Marketing Start Date | 1972-08-29 | 
| Marketing Category | BLA / BLA | 
| Application Number | BLA102192 | 
| Labeler Name | Nelco Laboratories, Inc. | 
| Substance Name | BLACKBERRY | 
| Active Ingredient Strength | 0 g/mL | 
| NDC Exclude Flag | E | 
| Listing Certified Through | 2017-12-31 | 
| Marketing Start Date | 1972-08-29 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | BLA | 
| Application Number | BLA102192 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 1972-08-29 | 
| Inactivation Date | 2019-10-21 | 
| Marketing Category | BLA | 
| Application Number | BLA102192 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 1972-08-29 | 
| Inactivation Date | 2019-10-21 | 
| Marketing Category | BLA | 
| Application Number | BLA102192 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 1972-08-29 | 
| Inactivation Date | 2019-10-21 | 
| Marketing Category | BLA | 
| Application Number | BLA102192 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 1972-08-29 | 
| Inactivation Date | 2019-10-21 | 
| Ingredient | Strength | 
|---|---|
| BLACKBERRY | .1 g/mL | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 36987-1298 | Blackberry | Blackberry | 
| 36987-1299 | Blackberry | Blackberry | 
| 36987-1300 | Blackberry | Blackberry | 
| 36987-1301 | Blackberry | Blackberry | 
| 49288-0054 | Blackberry | Blackberry | 
| 54575-353 | BLACKBERRY | blackberry |